Skip to content

Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage

Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04331171
Acronym
COVID CALL 15
Enrollment
12000000
Registered
2020-04-02
Start date
2020-03-17
Completion date
2020-11-15
Last updated
2021-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

M-health, COVID-19, Self-assessment application, epidemiology, symptoms

Brief summary

A coronavirus pandemic began on 12/31/2020 with the first Chinese patient. As of 3/16/2020, the epidemic affects more than 100 countries with 169,000 official infections and 6,500 deaths. This virus causes a pathology ranging from simple flu symptoms in 80% of cases to acute respiratory distress syndromes requiring resuscitation in 5% of cases and a death rate of 1.4 to 4% of cases. The arrival in France on 02/25/2020 with an exponential development of the infection (more than 5,000 cases on 03/15/2020) was accompanied by an unprecedented number of calls to the French emergency service call number (15) of worried patients with overload and sometimes saturation of the service that can impact calls and the care of patients really recovering from an emergency. We previously developed a Moovcare® web application which showed a 7 months survival benefit by early detection of relapsed lung cancer based on the reporting of patient symptoms analyzed by a validated algorithm in 300 patients and 1 trial randomized. Another application for detecting and monitoring chemo-induced febrile aplasia appears to show a reduction in the number of hospitalizations for sepsis. Finally, Smokecheck, a self-assessment application for symptoms by smokers, has shown that it improves the detection of symptomatic operable bronchial cancers (9 to 24%, p = 0.04). The web application https://www.maladiecoronavirus.fr/ was developed with a group of physicians from the Institut Pasteur, Hospitals group of Paris, Hospitals of Lille and Rennes and the ILC Jean Bernard in Le Mans. It makes it possible to guide symptomatic patients and patients who wishing to know what to do (call their general practitioner, teleconsultation, or call emergency service) based on symptoms and predictive factors of severity. Following the availability of this new tool, we want to assess the impact of the application on the number and relevance of calls to emergency service.

Interventions

DEVICEWeb application users

questionnaire of comorbidity and symptoms completed by the patient on his smartphone

Sponsors

Institut Pasteur
CollaboratorINDUSTRY
Assistance Publique - Hôpitaux de Paris
CollaboratorOTHER
DOCAPOST
CollaboratorUNKNOWN
Direction Générale de l'Offre de Soins
CollaboratorOTHER_GOV
Weprom
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All users of the https://www.maladiecoronavirus.fr/ application over the age of 18

Exclusion criteria

* not applicable

Design outcomes

Primary

MeasureTime frameDescription
To assess of the evolution of the number of calls to Emergency service within 12 days after the launch of the application https://www.maladiecoronavirus.fr/12 daysNumber of calls to Emergency service after the launch of web application comparded to the days before
To assess of the evolution of the proportion of relevant calls to Emergency service within 12 days after the launch of the application https://www.maladiecoronavirus.fr/12 daysNumber of relevants calls to Emergency service after the launch of web application comparded to the days before

Secondary

MeasureTime frameDescription
To assess the evolution over time of the COVID 19 epidemic3 monthsthe symptoms collected by the application
To assess the evolution over space of the COVID 19 epidemic3 monthsthe symptoms collected by the application according to ZIP code
To assess symptoms3 monthsDescriptive analysis of symptoms collected by web-application
To assess the users population3 monthsDescriptive analysis of data collected by web-application

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026